Use of Biologic Agents for Lip and Cheek Reconstruction.
Autor: | Depani M; Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas., Ferry AM; Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.; Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas., Grush AE; Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.; Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas., Moreno TA; Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas., Jones LM; Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.; Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas., Thornton JF; Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas. |
---|---|
Jazyk: | angličtina |
Zdroj: | Seminars in plastic surgery [Semin Plast Surg] 2021 Dec 31; Vol. 36 (1), pp. 26-32. Date of Electronic Publication: 2021 Dec 31 (Print Publication: 2022). |
DOI: | 10.1055/s-0041-1741399 |
Abstrakt: | The unique requirements of reconstructing cheek defects, often with its proximity to the mobile elements of the face including the lip and the eyelid, have been met very handily with the directed and thoughtful use of biologic wound healing agents. One of the key advantages of these agents is their ability to provide coverage for the mobile elements of the cheek and the lip in patients with multiple co-morbidities. These agents are successfully used where the standard cheek closure techniques including cervicofacial advancement flap are contraindicated due to its anesthetic requirement. Additionally, lip reconstruction involves examining the lip's three anatomic layers: mucosa, muscle, and skin. The defects must be planned for reconstruction based on the involvement of these layers. This paper serves to introduce the use of biologic wound healing agents depending on the involvement of these layers. The authors provide specific illustrations of these agents based on defect location, tissue involvement, and severity of the defect to help with procedural planning to reconstruct a very aesthetically involved part of the face. Competing Interests: Conflict of Interest None declared. (Thieme. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |